Richard DiCioccio - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Genetics, Molecular Biology, Oncology, Biostatistics Biology

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Peng M, Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers. Genes & Cancer. 4: 15-25. PMID 23946868 DOI: 10.1177/1947601913486344  0.458
2011 Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, Pharoah PD, Song H, Hogdall E, Kjaer SK, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Gentry-Maharaj A, Menon U, et al. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. International Journal of Cancer. Journal International Du Cancer. 128: 936-43. PMID 20473893 DOI: 10.1002/Ijc.25403  0.319
2010 Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. Bmc Cancer. 10: 47. PMID 20167074 DOI: 10.1186/1471-2407-10-47  0.388
2010 Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, ... ... DiCioccio RA, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861  0.407
2009 Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, Fridley BL, Gentry-Maharaj A, Menon U, Hogdall E, ... ... DiCioccio R, et al. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. British Journal of Cancer. 101: 1461-8. PMID 19738611 DOI: 10.1038/Sj.Bjc.6605284  0.463
2009 Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424  0.441
2009 Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Goode EL, Schildkraut JM, Easton DF, Krüger-Kjaer S, Whittemore AS, et al. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. Plos One. 4: e5983. PMID 19543528 DOI: 10.1371/Journal.Pone.0005983  0.457
2009 Tayo BO, DiCioccio RA, Liang Y, Trevisan M, Cooper RS, Lele S, Sucheston L, Piver SM, Odunsi K. Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance. Plos One. 4: e5939. PMID 19536330 DOI: 10.1371/Journal.Pone.0005939  0.362
2009 Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138  0.44
2009 Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H, Hogdall E, Kjaer SK, Whittemore AS, DiCioccio R, Ramus SJ, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 935-44. PMID 19258477 DOI: 10.1158/1055-9965.Epi-08-0860  0.348
2009 Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947  0.343
2009 Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, ... ... DiCioccio RA, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820  0.374
2009 South SA, Vance H, Farrell C, DiCioccio RA, Fahey C, Piver MS, Rodabaugh KJ. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers. Cancer. 115: 324-33. PMID 19117025 DOI: 10.1002/cncr.24012  0.452
2008 Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, ... ... Dicioccio RA, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548  0.404
2008 Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N, et al. Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer. Cancer Research. 68: 8837-42. PMID 18974127 DOI: 10.1158/0008-5472.Can-08-2363  0.413
2008 Mann A, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, et al. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. European Journal of Cancer (Oxford, England : 1990). 44: 2259-65. PMID 18723338 DOI: 10.1016/J.Ejca.2008.07.010  0.338
2008 Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 29: 1963-6. PMID 18660546 DOI: 10.1093/carcin/bgn172  0.303
2008 Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. Journal of the National Cancer Institute. 100: 962-6. PMID 18577746 DOI: 10.1093/Jnci/Djn190  0.406
2008 Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 123: 380-8. PMID 18431743 DOI: 10.1002/Ijc.23448  0.353
2008 Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British Journal of Cancer. 98: 282-8. PMID 18219286 DOI: 10.1038/Sj.Bjc.6604170  0.526
2007 Beesley J, Jordan SJ, Spurdle AB, Song H, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Pharoah PD, Webb PM, Chenevix-Trench G, et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2557-65. PMID 18086758 DOI: 10.1158/1055-9965.Epi-07-0542  0.374
2007 Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human Mutation. 28: 1207-15. PMID 17688236 DOI: 10.1002/Humu.20599  0.494
2007 Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261  0.416
2007 Ramus SJ, Harrington PA, Pye C, Peock S, Cook MR, Cox MJ, Jacobs IJ, DiCioccio RA, Whittemore AS, Piver MS, EMBRACE, Easton DF, Ponder BA, Pharoah PD, Gayther SA. Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online. Human Mutation. 28: 525-6. PMID 17397054 DOI: 10.1002/Humu.9493  0.367
2007 Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, Pharoah PD. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. Plos One. 2: e268. PMID 17342202 DOI: 10.1371/Journal.Pone.0000268  0.447
2006 Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, Easton DF, Jacobs IJ, Ponder BA, et al. Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Research. 66: 10220-6. PMID 17047088 DOI: 10.1158/0008-5472.Can-06-2222  0.363
2006 Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjaer SK, Pharoah PD, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis. 27: 2235-42. PMID 16774946 DOI: 10.1093/Carcin/Bgl089  0.402
2006 Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 359-63. PMID 16492929 DOI: 10.1158/1055-9965.Epi-05-0687  0.687
2005 Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. International Journal of Cancer. Journal International Du Cancer. 117: 611-8. PMID 15924337 DOI: 10.1002/Ijc.21047  0.353
2005 Lauffart B, Vaughan MM, Eddy R, Chervinsky D, DiCioccio RA, Black JD, Still IH. Aberrations of TACC1 and TACC3 are associated with ovarian cancer. Bmc Women's Health. 5: 8. PMID 15918899 DOI: 10.1186/1472-6874-5-8  0.384
2005 Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G. BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. Gynecologic Oncology. 97: 807-12. PMID 15904951 DOI: 10.1016/J.Ygyno.2005.03.007  0.364
2005 Whittemore AS, Balise RR, Pharoah PDP, DiCioccio RA, Narod SA. Increasing duration of OC use was associated with decreasing risks of ovarian cancer in BRCA1/2 carriers Evidence-Based Obstetrics and Gynecology. 7: 155-156. DOI: 10.1016/J.Ebobgyn.2005.05.004  0.436
2004 Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 2078-83. PMID 15598764  0.665
2004 Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 91: 1911-5. PMID 15545966 DOI: 10.1038/Sj.Bjc.6602239  0.488
2004 Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, et al. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1589-94. PMID 15466974  0.377
2004 McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. American Journal of Epidemiology. 160: 613-8. PMID 15383404 DOI: 10.1093/Aje/Kwh284  0.666
2004 Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity. Cancer Genetics and Cytogenetics. 153: 177-80. PMID 15350310 DOI: 10.1016/J.Cancergencyto.2004.01.020  0.686
2004 Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 23: 29-34. PMID 14668547 DOI: 10.1097/01.Pgp.0000101083.35393.Cd  0.39
2003 DiCioccio RA, Werness BA, Piver MS. BRCA1 mutations. Genes, Chromosomes & Cancer. 37: 222. PMID 12696073 DOI: 10.1002/gcc.10208  0.328
2003 Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Research. 63: 417-23. PMID 12543797  0.448
2001 Ostrow KL, DiCioccio RA, McGuire V, Whittemore AS. A BRCA1 variant, IVS23+1G→A, causes abnormal RNA splicing by deleting exon 23 Cancer Genetics and Cytogenetics. 127: 188-190. PMID 11428389 DOI: 10.1016/S0165-4608(01)00433-2  0.61
2000 Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Human Pathology. 31: 1420-4. PMID 11112219 DOI: 10.1016/S0046-8177(00)80014-3  0.36
2000 Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS. Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 19: 390-4. PMID 11109172 DOI: 10.1097/00004347-200010000-00017  0.521
2000 Piver MS, Tsukada Y, Werness BA, DiCioccio RA, Whittemore AS, Ponder BA. Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecologic Oncology. 78: 166-70. PMID 10926797 DOI: 10.1006/Gyno.2000.5840  0.354
2000 Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. Journal of the National Cancer Institute. 92: 1088-91. PMID 10880552 DOI: 10.1093/Jnci/92.13.1088  0.461
2000 DiCioccio RA. Literature on BRCA1 mutations not cited [2] American Journal of Pathology. 156: 1478. PMID 10753122  0.315
1999 Tworek H, Peng R, Fetzer S, Werness BA, Piver MS, Allen HJ, Dicioccio RA. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors Cancer Genetics and Cytogenetics. 112: 105-118. PMID 10686936 DOI: 10.1016/S0165-4608(98)00267-2  0.387
1999 Fetzer S, Tworek HA, Piver MS, DiCioccio RA. Classification of IVS1-10T→C as a polymorphism of BRCA1 Cancer Genetics and Cytogenetics. 113: 58-64. PMID 10459348 DOI: 10.1016/S0165-4608(99)00005-9  0.412
1998 Dicioccio RA, Werness BA, Peng R, Allen HJ, Piver MS. Correlation of TP53 mutations and p53 expression in ovarian tumors Cancer Genetics and Cytogenetics. 105: 93-102. PMID 9723023 DOI: 10.1016/S0165-4608(98)00011-9  0.33
1996 Foster KA, Harrington P, Kerr J, Russell P, DiCioccio RA, Scott IV, Jacobs I, Chenevix-Trench G, Ponder BA, Gayther SA. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Research. 56: 3622-5. PMID 8705994  0.474
1994 Steichen-Gersdorf E, Gallion HH, Ford D, Girodet C, Easton DF, DiCioccio RA, Evans G, Ponder MA, Pye C, Mazoyer S. Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. American Journal of Human Genetics. 55: 870-5. PMID 7977348  0.429
1994 Smith SA, DiCioccio RA, Struewing JP, Easton DF, Gallion HH, Albertsen H, Mazoyer S, Johansson B, Steichen-Gersdorf E, Stratton M, Ford D, Marshall G, White RL, Piver MS, Ponder BAJ. Localisation of the breast-ovarian cancer susceptibility gene (BRCAI) on 17q12-21 to an interval of ≤1 cM Genes Chromosomes and Cancer. 10: 71-76. PMID 7519878  0.411
Show low-probability matches.